Cortex XSIAM vs Recursion
Side-by-side comparison to help you choose the best tool.
Cortex XSIAM
paidPalo Alto Networks' AI-driven security operations platform that consolidates SIEM, SOAR, and endpoint detection into one AI SOC platform. XSIAM uses AI to automatically investigate and close up to 99% of alerts without analyst involvement, dramatically reducing mean time to respond. The platform integrates threat intelligence from Unit 42 and enforces consistent security policies across the environment.
Recursion
paidRecursion is a clinical-stage biotechnology company using AI to industrialise drug discovery. It combines large biological image datasets with ML to identify disease-biology relationships and predict therapeutic candidates. Recursion's platform has generated one of the largest proprietary biological datasets in existence, enabling AI-driven target identification and compound screening at new scale.
| Feature | Cortex XSIAM | Recursion |
|---|---|---|
| Pricing | paid | paid |
| Category | Data & Analytics | Data & Analytics |
| Rating | 4.7 | 4.4 |
| Best For | Large enterprises looking to modernise their SOC with a unified AI-driven platform | Pharmaceutical partners seeking AI drug discovery collaboration with one of the world's leading clinical-stage AI biotech companies |
| Views | 104 | 103 |
| Attribute | Cortex XSIAM | Recursion |
|---|---|---|
| Pricing Type | paid | paid |
| Free Trial | No | No |
| API Available | No | No |
| Mobile App | No | No |
| Rating | 4.7 ✓ | 4.4 |
| Founded | - | - |
| Team Size | - | - |
| Deployment | - | - |
| Popularity (Views) | 104 ✓ | 103 |
Pros
- Dramatically reduces alert fatigue through AI automation
- Single platform eliminates tool sprawl in SOC
- Strong threat intelligence from Unit 42 research team
Cons
- Premium enterprise pricing with complex licensing
- Migration from existing SIEM can be resource-intensive
Pros
- Pioneer in AI-driven drug discovery at scale
- Proprietary dataset is a competitive moat
- Active clinical programmes validate the approach
Cons
- Pharmaceutical industry-specific
- Platform not publicly available
- AI-driven alert triage and auto-closure
- Unified SIEM, SOAR, and EDR platform
- Unit 42 threat intelligence integration
- Automated incident response workflows
- Behavioural analytics and UEBA
- AI-powered target identification
- Large-scale biological image analysis
- ML compound screening
- Disease-biology mapping
- Partnership programs
Want to compare Cortex XSIAM with another tool?
Compare another tool